HCA Healthcare Reports Fourth Quarter 2024 Results and Provides 2025 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Citi highlights best Gen AI stocks to own for 2027
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Netflix raises prices in Germany and Austria, Citi comments
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Mizuho Reiterates Outperform Rating on HCA Healthcare Inc (HCA)
January 27, 2025 11:46 AM ESTMizuho analyst Ann Hynes reiterated an Outperform rating and $425.00 price target on HCA Healthcare Inc (NYSE: HCA).
The analyst comments "We are maintaining our price target of $425, and our 2025E-2026E adjusted EBITDA estimates, while increasing our 2025E-2026E adjusted EPS estimates driven by... More
HCA Healthcare Inc (HCA) PT Lowered to $404 at Leerink Partners
January 27, 2025 6:23 AM ESTLeerink Partners analyst Whit Mayo lowered the price target on HCA Healthcare Inc (NYSE: HCA) to $404.00 (from $460.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: Reiterate Outperform rating. 4Q24 results brought forth a continuation of strong demand trends, good cost controls and... More
HCA Holdings (HCA) Tops Q4 EPS by 8c, Offers Guidance, Approves $10B Buyback
January 24, 2025 7:34 AM ESTHCA Holdings (NYSE: HCA) reported Q4 EPS of $6.22, $0.08 better than the analyst estimate of $6.14. Revenue for the quarter came in at $18.29 billion versus the consensus estimate of $18.23 billion.
The HCA Healthcare, Inc. Board of Directors has authorized an additional share... More